Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Companion Animals

Set Alert for Companion Animals

Medical marijuana pet bill introduced in New York

A new bill has been introduced in the New York State of Assembly to enable veterinarians to prescribe medical marijuana for pets.

United States Pain

US gene therapy specialist Scout Bio secures series A

A spin-out from the University of Pennsylvania has received funding to develop gene therapies for companion animals.

North America United States

MSD set to grow Bravecto in Europe with positive opinion for cats

MSD Animal Health is close to extending the indications for its leading Bravecto portfolio in Europe with a new approval.

Europe Antiparasitics

AHI study details animal health's prominent contribution to the US economy

The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).

United States Antiparasitics

ASU bags grant for efficacy trial of multivalent cancer vaccine for dogs

A researcher at Arizona State University (ASU) has been awarded $6.4 million to test a preventative canine cancer vaccine.

Vaccines Canine

Aratana signals growing clinic access: 'Two-thirds of vets are using Galliprant'

Aratana Therapeutics has been commercializing three products for around a year now with the Kansas-based firm recording its first significant annual revenues. Animal Pharm editor Joseph Harvey spoke to president and chief executive Steven St. Peter in Boston following the release of the company's most recent financial results about Aratana's success is accessing clinics.

Companion Animals R&D

Animal Pharm Podcast #9: Mark Heffernan explains Stonehaven Incubate's game plan

Stonehaven Incubate has been launched to translate innovation in the human health space into new animal health companies. Animal Pharm Joseph Harvey editor spoke to the firm's chief executive Mark Heffernan about this new home for start-ups. 

R&D Pharmaceuticals

Panion broadens expertise with appointment for clinical trial

Panion Animal Health has signed an agreement that will see its upcoming clinical studies benefit from the expertise of a well-reputed biostatistician. 

R&D Companion Animals

Petnet, Petnostics sign data-driven pet nutrition deal

US companion animal businesses Petnet and Petnostics have signed an agreement that will see the two firms integrate diagnostic data with nutrition. 

Deals Companion Animals

Poïesis populates pipeline with investment the missing link

US companion animal medicines firm Poïesis Therapeutics is now working on a pipeline of eight candidates in-licensed from human biotechnology companies. 

R&D Companion Animals

Mars adds investment capabilities to scope of pet business

Mars Petcare has created an investment fund for financing innovation in the companion animal market. 

Investments Companion Animals

Jaguar advances canine candidate toward conditional approval, shares improve

Jaguar Health has moved one step closer to commercialization of its Canalevia treatment for chemotherapy-induced diarrhea (CID) in dogs with an indication from the US FDA. 

Pharmaceuticals Canine
See All